Know What's Happening in Healthcare

Today's Healthcare Pulse

Allogene Therapeutics CEO David Chang to step down

Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.

Kansas Greenlights Laser Surgery by Optometrists
NewsApr 7, 2026

Kansas Greenlights Laser Surgery by Optometrists

Kansas Governor Laura Kelly signed legislation on March 13 allowing optometrists to perform laser capsulotomy and laser trabeculoplasty, expanding their drug‑prescribing authority to all non‑injection routes and adding minor surgical procedures. The change makes Kansas the 15th state to grant optometric...

By Healio
Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate
BlogApr 7, 2026

Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate

Retatrutide, a next‑generation GLP‑1/GIP/Glucagon agonist, appears to cause less nausea than semaglutide while delivering comparable weight‑loss efficacy, but early data show a modest increase in resting heart rate. Patient anecdotes highlight typical GLP‑1 side effects—transient nausea, bowel habit shifts, occasional...

By Rapamycin News
RFK Jr. Rewrites CDC Vaccine Panel Charter to Boost HHS Secretary Control
NewsApr 7, 2026

RFK Jr. Rewrites CDC Vaccine Panel Charter to Boost HHS Secretary Control

Health Secretary Robert F. Kennedy Jr. filed a Federal Register notice that revises the CDC’s Advisory Committee on Immunization Practices charter, allowing the HHS Secretary to directly select members. The change follows a judge’s order suspending Kennedy’s earlier, largely anti‑vaccine...

By Pulse
CRISPR Gene Edit Cuts LDL by 49% in Early Trial, Offering Durable Cholesterol Solution
NewsApr 7, 2026

CRISPR Gene Edit Cuts LDL by 49% in Early Trial, Offering Durable Cholesterol Solution

A CRISPR Therapeutics‑funded study of a single‑dose gene edit that disables the liver gene ANGPTL3 lowered LDL cholesterol by 49% and triglycerides by 55% in a 15‑patient trial. Results published in the New England Journal of Medicine last November have...

By Pulse
Navigating the Frontiers of Advanced Therapeutics and Operational Excellence
NewsApr 7, 2026

Navigating the Frontiers of Advanced Therapeutics and Operational Excellence

In 2026 the biopharma sector is juggling rapid advances in emerging modalities—viral vectors, multispecific antibodies and nucleic‑acid therapies—with heightened operational discipline. Companies are deploying patient‑derived xenograft models, 3‑D organoids and AI‑enhanced spectral flow cytometry to de‑risk next‑gen immunotherapies. Manufacturing focus...

By BioPharm International
The Best Red Light Therapy Devices for Joint Pain (2026 Guide)
BlogApr 7, 2026

The Best Red Light Therapy Devices for Joint Pain (2026 Guide)

The at‑home red light therapy market, valued at roughly $1.2 billion in 2024, is projected to reach $2.5 billion by 2033, driven by 2.5 million monthly searches and 59% YoY growth. Independent testing of 18+ devices using spectroradiometers, flicker analyzers, EMF and power...

By Outliyr — High Performance Longevity
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
BlogApr 7, 2026

Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report

The escalating U.S.-Iran conflict is choking key maritime and air routes, slashing global air‑cargo capacity by 22% and threatening the Strait of Hormuz and, potentially, the Bab al‑Mandeb. These chokepoints are vital for transporting active pharmaceutical ingredients (APIs) and finished...

By Pharmaceutical Executive (independent trade outlet)
Next Reconciliation Bill to Target Healthcare
NewsApr 7, 2026

Next Reconciliation Bill to Target Healthcare

Congressional leaders are drafting a new budget reconciliation bill, slated for possible enactment by July, that will target healthcare spending to help fund roughly $64 billion for the Department of Homeland Security and $200 billion for the ongoing Iran conflict. The bill...

By HFMA – Healthcare Financial Management Association
New State Records Show Gateway Community Services Paid Back $118k of Alleged $1.6 Million in "Over Payments"
BlogApr 7, 2026

New State Records Show Gateway Community Services Paid Back $118k of Alleged $1.6 Million in "Over Payments"

State records reveal MaineCare provider Gateway Community Services allegedly overbilled Medicaid by roughly $1.6 million but has repaid only $118,431.58, about seven cents for every dollar claimed. The repayments, made in a structured pattern from 2019 through 2025, suggest a formal...

By The Robinson Report
Front-of-Package Labels Are Already Shaping Shopper Behaviour
NewsApr 7, 2026

Front-of-Package Labels Are Already Shaping Shopper Behaviour

Canada’s Health Canada launched mandatory front‑of‑package (FOP) nutrition warning labels on Jan. 1. Early data shows 56% of shoppers are aware of the symbols, while 57% say the warnings would affect their buying choices. Price remains the dominant purchase driver for...

By Canadian Grocer
Welltower Buys Palm Beach County Assisted Living Facility for $87M
NewsApr 7, 2026

Welltower Buys Palm Beach County Assisted Living Facility for $87M

Welltower, the senior‑living REIT, acquired The Arbor at Lake Worth in Florida for $87.2 million, a price roughly 36 percent higher than the $64 million paid two years earlier. The 366,000‑square‑foot campus houses 377 assisted‑living units, a recreation center, auditorium and a nursing...

By Commercial Observer
Trump’s VA Budget Request Tops $488 Billion for Fiscal 2027
NewsApr 7, 2026

Trump’s VA Budget Request Tops $488 Billion for Fiscal 2027

The White House’s FY2027 budget request proposes a 7.7% increase for the Department of Veterans Affairs, lifting its total to a record $488 billion. The plan allocates $205.6 billion in discretionary spending and $282.6 billion in mandatory funds, funding new facilities, a medical...

By Military Times
CEOs' Blindness to Healthcare Costs Fuels Overcharges
SocialApr 7, 2026

CEOs' Blindness to Healthcare Costs Fuels Overcharges

Almost right. It’s more expensive because CEOs of self insured companies, hire the biggest insurance companies to manage their spend on care. Resulting in them having no idea how they spend their money. Look up those same prices...

By Mark Cuban
Did Eli Lilly Just Strike Another Gold Mine?
NewsApr 7, 2026

Did Eli Lilly Just Strike Another Gold Mine?

Eli Lilly announced a $1.5 billion acquisition of a biotech portfolio centered on orexin‑targeting therapeutics. The deal adds late‑stage candidates for insomnia, narcolepsy and metabolic disorders to Lilly’s central‑nervous‑system pipeline. Analysts estimate the combined market for orexin drugs could surpass $10 billion by...

By Endpoints News
What’s Familiar in Health Tech’s Q1 Funding Totals
NewsApr 7, 2026

What’s Familiar in Health Tech’s Q1 Funding Totals

Health‑tech funding surged in Q1, highlighted by Whoop’s $575 million Series G round that lifted its valuation into the multibillion‑dollar range. Smaller but notable deals included OpenEvidence, eMed, Talkiatry and Alphabet’s Verily, each securing tens of millions to expand data, telehealth, AI‑driven...

By Endpoints News
The Building Blocks of Data Literacy for Healthcare
NewsApr 7, 2026

The Building Blocks of Data Literacy for Healthcare

Dean Burrill of CDW argues that data literacy is the foundation for trustworthy AI in healthcare. He stresses that organizations must know what data they have, its quality, and its sensitivity before feeding it into AI models. Effective data governance...

By HealthTech Magazine
Pharmaceutical Executive Daily: Wegovy HD Now Available in the U.S.
BlogApr 7, 2026

Pharmaceutical Executive Daily: Wegovy HD Now Available in the U.S.

Novo Nordisk has rolled out Wegovy HD, a 7.2 mg weekly semaglutide injection, across the United States, delivering an average 20.7% weight loss in trials—significantly higher than the 2.4 mg dose. The FDA approved the product in March under its National Priority Review...

By Pharmaceutical Executive (independent trade outlet)
WHO and France Shift One Health Vision to Action with New High-Impact Initiatives
NewsApr 7, 2026

WHO and France Shift One Health Vision to Action with New High-Impact Initiatives

On World Health Day, WHO and France hosted a One Health Summit that moved the interdisciplinary One Health concept into concrete action. The organization announced four flagship initiatives: a Global Network of One Health Institutions, an extended One Health High‑Level...

By World Health Organization
Bridging the Gap in Rural Dementia Care with Technology
BlogApr 7, 2026

Bridging the Gap in Rural Dementia Care with Technology

Rural dementia patients experience higher mortality, fewer physician visits, and longer hospital stays compared with urban peers. A new centralized resource app, “Resources for Individuals Living with Dementia and Their Families,” connects clinicians and caregivers to in‑home care, therapy, and...

By KevinMD
Study Suggests $35 Monthly Insulin Cap Has Increased Patient Access
NewsApr 7, 2026

Study Suggests $35 Monthly Insulin Cap Has Increased Patient Access

A 2023 Medicare policy capped insulin co‑payments at $35 per month, and a new study shows the limit sharply reduced patients' out‑of‑pocket spending in its first year. Average insulin expenditures fell by roughly 30%, while prescription fill rates climbed, indicating...

By Endpoints News
[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data
BlogApr 7, 2026

[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data

Project Glasswing warns that soon‑to‑be‑released AI agents are vulnerable to hidden prompt injections and memory‑poisoning attacks, with success rates as high as 86% and 80% respectively. DeepMind has identified six attack layers—from perception to human supervision—demonstrating proof‑of‑concept exploits that could...

By Rapamycin News
Stem Cell Therapy for Skin Rejuvenation: Safety, Benefits, and Recovery Time
NewsApr 7, 2026

Stem Cell Therapy for Skin Rejuvenation: Safety, Benefits, and Recovery Time

Stem cell therapy is gaining traction as a non‑surgical skin‑rejuvenation option, leveraging the body’s own regenerative cells to boost collagen and elastin. Clinical reports suggest visible improvements in texture and firmness within two to three weeks, with full benefits emerging...

By TechBullion
How AI Is Revolutionizing Senior Living: Insights From the 2026 CXO Summit
NewsApr 7, 2026

How AI Is Revolutionizing Senior Living: Insights From the 2026 CXO Summit

At the 2026 Long‑Term Care & Senior Living CXO Summit, senior‑living executives highlighted artificial intelligence as a strategic lever to address workforce shortages and the looming Boomer surge. AI tools such as predictive analytics, wearable monitoring and virtual assistants are...

By PM360
AI Tool Predicts Barrett’s Esophagus Recurrence with High Accuracy
NewsApr 7, 2026

AI Tool Predicts Barrett’s Esophagus Recurrence with High Accuracy

Researchers have created a machine‑learning tool that predicts recurrence of Barrett's esophagus after endoscopic eradication therapy with over 90% accuracy. The model was trained on clinical data from more than 2,500 patients and can also estimate the timing of recurrence,...

By News-Medical.Net
[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data
BlogApr 7, 2026

[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data

Project Glasswing warns that emerging AI models could become vectors for massive cyber‑attacks, citing an 86% success rate for hidden prompt‑injection attacks and a 0.1% poisoned‑data threshold that corrupts agents with over 80% certainty. DeepMind identifies six attack layers—perception, reasoning,...

By Rapamycin News
Yuviwel Gets FDA Greenlight as First Once‑Weekly Treatment for Dwarfism in Children
BlogApr 7, 2026

Yuviwel Gets FDA Greenlight as First Once‑Weekly Treatment for Dwarfism in Children

Ascendis Pharma’s Yuviwel (navepegritide) received FDA approval as the first once‑weekly therapy for achondroplasia in children aged two and older. The drug, a TransCon CNP formulation, showed a 1.5 cm greater annual height gain versus placebo in a 52‑week trial and...

By Xtalks – Biotech Blogs
Germinal Centers in Thymus Act as Prognostic Factor in Thymoma-Associated Myasthenia Gravis
NewsApr 7, 2026

Germinal Centers in Thymus Act as Prognostic Factor in Thymoma-Associated Myasthenia Gravis

A new study in the Journal of Neuroimmunology finds that ectopic germinal centers (GCs) in the thymus serve as a prognostic marker for poorer outcomes in thymoma‑associated myasthenia gravis (TAMG). Among 111 patients who underwent thymectomy, 62.2% had at least...

By AJMC (The American Journal of Managed Care)
Promising Study Links Coffee Consumption To Reduced Dementia Risk
NewsApr 7, 2026

Promising Study Links Coffee Consumption To Reduced Dementia Risk

A new JAMA study of more than 100,000 health professionals followed for four decades found that regular consumption of caffeinated coffee is associated with a roughly 50% lower risk of developing dementia. The protective effect peaked at two to three...

By Forbes – Healthcare
Should Clinics Prescribe Medicinal Cannabis that They Also Supply? We Asked 5 Experts
NewsApr 7, 2026

Should Clinics Prescribe Medicinal Cannabis that They Also Supply? We Asked 5 Experts

Australian medicinal cannabis prescriptions have exploded, driven by convenient online consultations and one‑stop‑shop models that combine prescribing with dispensing. Critics label this vertical integration a conflict of interest, arguing that clinics may prioritize profit over patient safety and prescribe unapproved...

By The Conversation – Fashion (global)
White House Adds AbbVie's Humira to TrumpRx Alongside Cheaper Biosimilars
NewsApr 7, 2026

White House Adds AbbVie's Humira to TrumpRx Alongside Cheaper Biosimilars

The White House’s drug‑discount portal TrumpRx now lists AbbVie’s Humira at $950 per month, a steep cut from its typical $5,000‑plus price. The listing appears alongside two lower‑cost biosimilars that target the same inflammatory conditions. TrumpRx aims to provide seniors...

By Endpoints News
Empath Health, Trustbridge Solidify Affiliation
NewsApr 7, 2026

Empath Health, Trustbridge Solidify Affiliation

Empath Health and Trustbridge have completed a two‑year affiliation, creating Empath Trustbridge Hospice, which now cares for roughly one‑in‑five hospice patients daily in Florida. The merged nonprofit combines the reach of multiple hospice foundations, serving over 100,000 patients across a...

By Hospice News
What Is Value-Based Care? A Comprehensive Guide to Transforming Healthcare
NewsApr 7, 2026

What Is Value-Based Care? A Comprehensive Guide to Transforming Healthcare

Value‑Based Care (VBC) is reshaping U.S. healthcare by tying provider payments to patient outcomes rather than service volume. Since the Affordable Care Act introduced ACOs and bundled payments, VBC programs have saved billions, prompting payers, providers, and patients to adopt...

By PM360
First In-Room MRI-Guided Breast Biopsy System Gets FDA Clearance
BlogApr 7, 2026

First In-Room MRI-Guided Breast Biopsy System Gets FDA Clearance

Mammotome received FDA clearance for the Prima MR system, the first in‑room MRI‑guided vacuum‑assisted breast biopsy platform, alongside its HydroMARK Plus MR biopsy site markers. The system lets clinicians perform biopsies directly inside the MRI suite, eliminating patient transfers and streamlining...

By Xtalks – Biotech Blogs
Judge Again Tells Trump Admin To Recognize VA Health Workers’ Union
NewsApr 7, 2026

Judge Again Tells Trump Admin To Recognize VA Health Workers’ Union

A federal judge has again ordered the Trump administration to recognize the collective bargaining agreement for health‑care workers at the Department of Veterans Affairs. The ruling insists the government comply “in both form and substance,” effectively overturning prior attempts to...

By Inside Health Policy
How Diagnostic Overshadowing Delays Hyperprolactinemia Care
BlogApr 7, 2026

How Diagnostic Overshadowing Delays Hyperprolactinemia Care

A 32‑year‑old woman endured 15 years of persistent galactorrhea after clinicians dismissed her elevated prolactin as a behavioral issue. Despite prolactin levels of 44‑60 ng/mL and no medication or thyroid causes, she was never referred for pituitary imaging. The article highlights how...

By KevinMD
Magnetic Coil Setup Guides Microrobots without Seeing Them
NewsApr 7, 2026

Magnetic Coil Setup Guides Microrobots without Seeing Them

SMU researchers have built a triaxial Helmholtz coil system that creates a uniform magnetic field gradient, enabling microrobots to be guided without continuous visual tracking. The six‑coil arrangement, calibrated with a triaxial magnetometer and refined by Tikhonov regularization, delivers consistent...

By Tech Xplore Robotics
Geographic Disparities Persist in the Decline of U.S. Cancer Deaths
NewsApr 7, 2026

Geographic Disparities Persist in the Decline of U.S. Cancer Deaths

Researchers from Mississippi State University and Oak Ridge National Laboratory analyzed nearly 3,000 U.S. counties from 1981 to 2019, confirming that the nationwide decline in cancer deaths has been uneven. Urban, affluent counties experienced the steepest mortality reductions, while rural...

By News-Medical.Net
SDOH Drive Disparities in NGS Access Across Cancers
NewsApr 7, 2026

SDOH Drive Disparities in NGS Access Across Cancers

A JAMA Network Open study of 63,294 U.S. patients with advanced cancers found that social determinants of health (SDOH) significantly delay or prevent next‑generation sequencing (NGS) testing. Low socioeconomic status, Hispanic and non‑Hispanic Black ethnicity, Medicaid or Medicare coverage, and...

By AJMC (The American Journal of Managed Care)
Re: Who Would Want to Be a Clinical Academic? Pathway to a Sustainable Workforce
NewsApr 7, 2026

Re: Who Would Want to Be a Clinical Academic? Pathway to a Sustainable Workforce

A recent BMJ rapid response highlights a deepening crisis in the UK clinical academic workforce, noting that only 40% of physicians are engaged in research and that recent cuts to incentives—National Clinical Impact Awards now capped at £20,000–£40,000 (≈$25,000–$50,000) versus...

By BMJ (Latest)
Newly Developed Smart Molecules Offer a Safer and More Precise Approach to Cancer Care
NewsApr 7, 2026

Newly Developed Smart Molecules Offer a Safer and More Precise Approach to Cancer Care

Researchers at NYU Abu Dhabi have created manganese‑based smart molecules that act as both MRI contrast agents and cancer therapeutics. The compounds stay inert in healthy tissue and activate in the acidic micro‑environment of tumors, releasing manganese ions that enhance...

By News-Medical.Net
Lest We "Off" Ourselves (Cautionary Examples)
BlogApr 7, 2026

Lest We "Off" Ourselves (Cautionary Examples)

Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson suffered severe sepsis after receiving experimental stem‑cell and regenerative‑medicine injections from Dr. Adil Khan’s unregulated clinics. The series links spinal injections and intravenous therapies to life‑threatening infections, highlighting the...

By Rapamycin News
Outcomes of Treatment for Methicillin-Resistant Staphylococcus Aureus Ventilator-Associated Pneumonia
NewsApr 7, 2026

Outcomes of Treatment for Methicillin-Resistant Staphylococcus Aureus Ventilator-Associated Pneumonia

A retrospective study of 125 patients with MRSA‑associated ventilator‑associated pneumonia compared trimethoprim‑sulfamethoxazole (SMX‑TMP) to the standard vancomycin therapy. Mortality was 28% with SMX‑TMP versus 37% with vancomycin, a difference that was not statistically significant. Clinical cure rates at day 5 and...

By Research Square – News/Updates
Combination of Ranibizumab, Dexamethasone Superior to Ranibizumab Alone for Macular Edema
NewsApr 7, 2026

Combination of Ranibizumab, Dexamethasone Superior to Ranibizumab Alone for Macular Edema

A retrospective real‑world study of 139 eyes with non‑ischemic retinal vein occlusion‑related macular edema found that sequential ranibizumab followed by a dexamethasone implant yielded superior visual outcomes compared with three monthly ranibizumab injections alone. At three months, the combination group...

By AJMC (The American Journal of Managed Care)
US Obesity Rates Dip in 2023, Drug Impact Suspected
SocialApr 7, 2026

US Obesity Rates Dip in 2023, Drug Impact Suspected

BMI and obesity prevalence in the US decreased in 2023 for the first time in more than a decade. What s the reason? Are people 'exercising more and eating less' or are GLP-1 agonists starting to have an effect? https://jamanetwork.com/journals/jama-health-forum/fullarticle/2827712 @GatlanHealth

By Robert Lufkin, MD
Blueprint for Integrating Psilocybin Into NHS Mental Health Care
SocialApr 7, 2026

Blueprint for Integrating Psilocybin Into NHS Mental Health Care

British Journal of Psychiatry Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin https://t.co/6sgfqg66rt

By Julie Holland
Parkinson's Disease
BlogApr 7, 2026

Parkinson's Disease

Recent preclinical and early clinical studies explore a range of nutraceuticals and repurposed drugs that target oxidative stress, metal homeostasis, and gut integrity in Parkinson’s disease. Benfotiamine combined with methylcobalamin showed symptomatic improvement in a case series and activates Nrf2...

By Rapamycin News
First Human Trial Tests Cellular Age Reversal Therapy
SocialApr 7, 2026

First Human Trial Tests Cellular Age Reversal Therapy

This method to reverse cellular ageing is about to be tested in humans A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely refresh aged tissues and organs. 💡"Technologies to refresh ageing tissue...

By David Barzilai, MD PhD
BPOC Sells Medical Device Firm Midwest Products & Engineering
NewsApr 7, 2026

BPOC Sells Medical Device Firm Midwest Products & Engineering

BPOC has finalized the sale of its medical‑device subsidiary, Midwest Products & Engineering, to private‑equity firm Graham Partners. The transaction transfers ownership of Midwest's manufacturing capabilities and client base to the new buyer. BPOC will use proceeds to refocus on...

By PE Hub
The Hidden Realities of the HIV/AIDS Epidemic and U.S. Health Care Policy
BlogApr 7, 2026

The Hidden Realities of the HIV/AIDS Epidemic and U.S. Health Care Policy

The United States recorded 39,200 new HIV diagnoses in 2023, with half of those cases concentrated in the Southeast, and roughly 1.2 million Americans remain living with HIV, one in eight of whom are unaware of their status. Over the past...

By KevinMD